AJP - Renal Physiology, Vol 258, Issue 2 414-F422, Copyright © 1990 by American Physiological Society

ARTICLES

Angiotensin II control of the renal microcirculation in rats with reduced renal mass

J. C. Pelayo, A. H. Quan and P. F. Shanley
Department of Pediatrics, University of Colorado School of Medicine, Denver 80262.

It has been suggested that angiotensin II (ANG II) activation after renal ablation contributes to the altered glomerular dynamics and proteinuria that characterizes this model of chronic renal failure. In the present study, male Munich-Wistar rats underwent 75% renal ablation (Nx group). Two weeks later, micropuncture studies were performed in sham-operated rats (sham group) and Nx group rats during intravenous infusion of either a vehicle or two ANG II inhibitors, namely [Sar1, Ala8]ANG II or MK-421 administered at a rate of 0.3 and 1 mg.kg body wt-1.h-1, respectively. Acute ANG II inhibition in sham group had no effect on mean arterial pressure (MAP), glomerular dynamics, or proteinuria. In contrast, in Nx group ANG II inhibition lessened glomerular hypertension (from 64.7 +/- 1.0 to 55.4 +/- 1.7 mmHg, P less than 0.0001) the result of postglomerular vasodilation (P less than 0.01), normalized the glomerular ultrafiltration coefficient (from 0.038 +/- 0.002 to 0.005 +/- 0.002 nl.s-1.mmHg-1, P less than 0.0001), and attenuated proteinuria (from 42.1 +/- 6.5 to 28.1 +/- 5.4 micrograms/min, P less than 0.01). MAP, single-nephron GFR and plasma flow were unaffected. These results suggest that ANG II activity is enhanced in nephrectomy, contributing in a major way to altered glomerular dynamics and proteinuria.

This article has been cited by other articles:

				P. Singh, A. Deng, R. C. Blantz, and S. C. Thomson Unexpected effect of angiotensin AT1 receptor blockade on tubuloglomerular feedback in early subtotal nephrectomy Am J Physiol Renal Physiol, May 1, 2009; 296(5): F1158 - F1165. [Abstract] [Full Text] [PDF]

				A. R. R. Goncalves, C. K. Fujihara, A. L. Mattar, D. M. A. C. Malheiros, I. L. Noronha, G. de Nucci, and R. Zatz Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatory Am J Physiol Renal Physiol, May 1, 2004; 286(5): F945 - F954. [Abstract] [Full Text] [PDF]

				P. L. Sanchez, L. M. Salgado, N. R. Ferreri, and B. Escalante Effect of Cyclooxygenase-2 Inhibition on Renal Function After Renal Ablation Hypertension, October 1, 1999; 34(4): 848 - 853. [Abstract] [Full Text] [PDF]

				J.-L. Wang, H.-F. Cheng, M.-Z. Zhang, James. A. McKanna, and R. C. Harris Selective increase of cyclooxygenase-2 expression in a model of renal ablation Am J Physiol Renal Physiol, October 1, 1998; 275(4): F613 - F622. [Abstract] [Full Text] [PDF]

				K. Kodama, H. Adachi, and J. Sonoda Beneficial Effects of Long-term Enalapril Treatment and Low-Salt Intake on Survival Rate of Dahl Salt-Sensitive Rats with Established Hypertension J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 625 - 629. [Abstract] [Full Text]

				J. Hernandez, H. Astudillo, and B. Escalante Angiotensin II stimulates cyclooxygenase-2 mRNA expression in renal tissue from rats with kidney failure Am J Physiol Renal Physiol, April 1, 2002; 282(4): F592 - F598. [Abstract] [Full Text] [PDF]